The Confidence of Aetna in Obamacare

Aetna Inc., with stock symbol AET is a diversified healthcare benefits firm, which began its operations on December 20, 1982. Aetna sells a range of traditional and consumer-directed healthcare products and related services, which includes pharmacy, dental, medical, behavioral health, life and disability plans, medical management services, Medicaid healthcare management services and health information exchange technology services. The firm conducts its operations in three business segments namely, Health Care, Group Insurance and Large Case Pensions. Generally, Aetna target customers who are employed, college students, health plans and healthcare providers, government units, government plans, labor groups and expatriates.

The current Aetna stock charts, when compared to its industry counterparts, reveal a similar decline in stock prices as concerns regarding the costs of Obamacare grew among citizens. Aetna stock prices are currently at the rate of $70.37, which is a1.24% decline than the previous days. As growing skepticism continues to influence its customer base, the life and health insurance industry is slowly declining. Aetna Inc. tried to solve this worsening situation by reporting to investors that Obamacare actually resulted to better results than what is predicted by some investors. Company outlook also went down due to the issue of Aetna’s acquisition of an $84,000 new hepatitis C drug by Gilead Sciences Inc. This spurred a global outcry over the rising costs of NVEL drugs. But in spite of all these, Aetna remains confidant that they will soon recoup growth once the benefits of Obamacare materialize in the firm.